Zusammenfassung
Lidocain ist ein Lokalanästhetikum vom Amidtyp, das zur Regionalanästhesie und zur i.v.-Behandlung ventrikulärer Herzrhythmusstörungen zugelassen ist. Inzwischen haben zahlreiche Studien gezeigt, dass eine perioperative i.v.-Lidocain-Infusion bei großen chirurgischen Operationen auch zu einer deutlichen postoperativen Schmerzreduktion mit vermindertem Opioidverbrauch und einer verbesserten Darmmotilität führen kann. In der vorliegenden Übersichtsarbeit werden Wirkmechanismen, mögliche Nebenwirkungen und die bisherigen klinischen Erfahrungen bei der Anwendung von Lidocain zur postoperativen Schmerztherapie dargestellt sowie praktische Hinweise zum klinischen Einsatz gegeben.
Abstract
Lidocaine is commonly used for regional anesthesia and nerve blocks. However, recent clinical studies demonstrated that intravenous perioperative administration of lidocaine can lead to better postoperative analgesia, reduced opioid consumption and improved intestinal motility. It can therefore be used as an alternative when epidural analgesia is contraindicated, not possible or not feasible. Apart from the sodium channel blocking effects relevant for regional anesthesia, lidocaine also has anti-inflammatory properties. Lidocaine can obviously inhibit the priming of resting neutrophilic granulocytes, which, simplified, may reduce the liberation of superoxide anions, a common pathway of inflammation after multiple forms of tissue trauma. At the authors’ institutions intravenous lidocaine is primarily used for postoperative pain relief following abdominal surgery and is given as a bolus dose of 1.5–2.0 mg/kg body weight (BW) injected over 5 min followed by an infusion of 1.5 mg/kg BW/h intraoperatively and 1.33 mg/kg BW/h postoperatively in the recovery room or in the intensive care unit (ICU). The lidocaine infusion is stopped in the recovery room 30 min before discharge or in the ICU at the latest after 24 h. Lidocaine is not used on normal wards. This overview summarizes the current evidence for the intravenous administration of lidocaine for patients undergoing different types of surgery and gives practical advice for its use.
Literatur
Apfelbaum JL, Chen C, Mehta SS, Gan TJ (2003) Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 97:534–540
AstraZeneca (2007) Fachinformation Xylocain 2% Kardiologie Mai 2007. AstraZeneca GmbH, Wedel, S 22876
AstraZeneca (2009) Fachinformation Xylocain 1% / 2% August 2009. AstraZeneca GmbH, Wedel, S 22876
Cassuto J, Wallin G, Hogstrom S et al (1985) Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 64:971–974
Condliffe AM, Kitchen E, Chilvers ER (1998) Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 94:461–471
Cooke ED, Bowcock SA, Lloyd MJ, Pilcher MF (1977) Intravenous lignocaine in prevention of deep venous thrombosis after elective hip surgery. Lancet 2:797–799
Cui W, Li Y, Li S et al (2010) Systemic administration of lidocaine reduces morphine requirements and postoperative pain of patients undergoing thoracic surgery after propofol-remifentanil-based anaesthesia. Eur J Anaesthesiol 27:41–46
Cui W, Li Y, Li S et al (2009) Systemic lidocaine inhibits remifentanil-induced hyperalgesia via the inhibition of cPKCgamma membrane translocation in spinal dorsal horn of rats. Neurosurg Anesthesiol 21:318–325
Clive-Lowe SG de, Gray PWS, North J (1954) Succinyldicholine and lignocaine by continuous intravenous drip: report of 1000 administrations. Anaesthesia 9:96–104
DeToledo JC (2000) Lidocaine and seizures. Ther Drug Monit 22:320–322
Deutsche Gesellschaft für Neurologie (2008) Leitlinie „Status epilepticus im Erwachsenenalter“. http://www.dgn.org/images/stories/dgn/leitlinien/LL2008/ll08kap_002.pdf. Zugriff 14.10.2010
El-Tahan M, Warda O, Diab D et al (2009) A randomized study of the effects of perioperative i.v. lidocaine on hemodynamic and hormonal responses of cesarean section. J Anesth 23:215–221
Gottschalk A, Gottschalk A (2010) Kontinuierliche Wundinfusion von Lokalanästhetika. Stellenwert in der postoperativen Schmerztherapie. Anaesthesist, doi 10.1007/s00101-010-1808-5
Groudine SB, Fisher HA, Kaufman RP Jr et al (1998) Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 86:235–239
Hans GA, Lauwick SM, Bonhomme V et al (2010) Intravenous lidocaine infusion reduces bispectral index-guided requirements of propofol only during surgical stimulation. Br J Anaesth 105:471–479
Herroeder S, Pecher S, Schonherr ME et al (2007) Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg 246:192–200
Hodgson PS, Liu SS (2001) Epidural lidocaine decreases sevoflurane requirement for adequate depth of anesthesia as measured by the bispectral index monitor. Anesthesiology 94:799–803
Hollmann MW, Durieux ME (2000) Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology 93:858–875
Hollmann MW, Strumper D, Durieux ME (2004) The poor man’s epidural: systemic local anesthetics for improving postoperative outcomes. Med Hypotheses 63:386–389
Hollmann MW, Strumper D, Herroeder S, Durieux ME (2005) Receptors, G proteins, and their interactions. Anesthesiology 103:1066–1078
Hollmann MW, Wieczorek KS, Berger A, Durieux ME (2001) Local anesthetic inhibition of G protein-coupled receptor signaling by interference with G-alpha(q) protein function. Mol Pharmacol 59:294–301
Insler SR, O’Connor M, Samonte AF, Bazaral MG (1995) Lidocaine and the inhibition of postoperative pain in coronary artery bypass patients. J Cardiothorac Vasc Anesth 9:541–546
Kaba A, Laurent SR, Detroz BJ et al (2007) Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology 106:11–18
Koppert W, Ostermeier N, Sittl R et al (2000) Low-dose lidocaine reduces secondary hyperalgesia by central mode of action. Pain 85:217–224
Koppert W, Weigand M, Neumann F et al (2004) Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 98:1050–1055
Kuo CP, Jao SW, Chen KM et al (2006) Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth 97:640–646
Lux EA, Haack T, Hinrichs K et al (2009) Ketaminrazemat bei „Fast-track-Anästhesie“ – Einfluss auf Aufwachzeiten und postoperativen Opioidbedarf. Anaesthesist 58:1027–1034
Marret E, Rolin M, Beaussier M, Bonnet F (2008) Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg 95:1331–1338
Martin F, Cherif K, Gentili ME et al (2008) Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology 109:118–123
McCarthy GC, Megalla SA, Habib AS (2010) Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs 70:1149–1163
McKay A, Gottschalk A, Ploppa A et al (2009) Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery. Anesth Analg 109:1805–1808
Nagy I, Woolf CJ (1996) Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 64:59–70
Rimback G, Cassuto J, Tollesson PO (1990) Treatment of postoperative paralytic ileus by intravenous lidocaine infusion. Anesth Analg 70:414–419
Shono A, Sakura S, Saito Y et al (2003) Comparison of 1% and 2% lidocaine epidural anaesthesia combined with sevoflurane general anaesthesia utilizing a constant bispectral index. Br J Anaesth 91:825–829
Sugimoto M, Uchida I, Mashimo T (2003) Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors. Br J Pharmacol 138:876–882
Wu CL, Tella P, Staats PS et al (2002) Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology 96:841–848
Yardeni IZ, Beilin B, Mayburd E et al (2009) The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 109:1464–1469
Interessenkonflikt
Die Autoren weisen auf folgende Beziehungen hin: W. Wilhelm hat für die Firmen Aspect, AstraZeneca, Baxter, B.Braun Melsungen, Dräger, Essex Pharma, Fresenius, GlaxoSmithKline, Narcotrend Monitortechnik, Storz u. a. Vorträge gehalten und/oder „consulting“ durchgeführt. André Gottschalk hat Vortragshonorare der Firmen AstraZeneca, B.Braun Melsungen, Baxter und MSD erhalten. Anna Herminghaus, Mario Wachowiak, Katharina Eggert und Antje Gottschalk haben keine Industriekontakte mit potenziellem Interessenkonflikt.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herminghaus, A., Wachowiak, M., Wilhelm, W. et al. Intravenös verabreichtes Lidocain zur perioperativen Schmerztherapie. Anaesthesist 60, 152–160 (2011). https://doi.org/10.1007/s00101-010-1829-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-010-1829-0
Schlüsselwörter
- Anästhetika, lokal
- Analgetikum, Opioid
- Antientzündliche Agenzien
- Medikamentendosisberechnung
- Schmerz, postoperativ